-
Company Insights
NewJohn Lewis – Digital Transformation Strategies
John Lewis Digital Transformation Strategies Overview John Lewis has been focusing on using AI, big data, cloud, robotics, contactless retail, innovation, digital twin, gaming, electric vehicles, and e-commerce to digitally transform its operations. The annual ICT spending of John Lewis was estimated at $297.9 million for 2023. A major share of this spending is earmarked for acquiring software, network and communications, and ICT services from vendors. John Lewis, the principal trading subsidiary of John Lewis Partnership Plc, owns and operates...
-
Product Insights
Lewy Body Dementia – Drugs In Development, 2023
Global Markets Direct’s, ‘Lewy Body Dementia - Drugs In Development, 2023’, provides an overview of the Lewy Body Dementia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lewy Body Dementia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fosgonimeton in Lewy Body Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fosgonimeton in Lewy Body Dementia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fosgonimeton in Lewy Body Dementia Drug Details: Fosgonimeton is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buntanetap Tartrate in Lewy Body Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buntanetap Tartrate in Lewy Body Dementia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buntanetap Tartrate in Lewy Body Dementia Drug Details: Buntanetap (ANVS-401...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UB-312 in Lewy Body Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UB-312 in Lewy Body Dementia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UB-312 in Lewy Body Dementia Drug Details: UB-312 is under...
-
Product Insights
S-28 Lewis Creek Mine
The S-28 Lewis Creek Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our S-28 Lewis Creek Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
Lewis Creek Power Plant
Lewis Creek Power Plant is a thermal project located in Texas, United States. The project is owned by Entergy Texas Inc. The project came online in 1970. Empower your strategies with our Lewis Creek Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
Lewis Ridge Pumped Storage project
Lewis Ridge Pumped Storage project is a Hydro project located in Kentucky, United States. The project is owned and being developed by Rye Development, LLC. The project is at the permitting stage. Empower your strategies with our Lewis Ridge Pumped Storage project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bosutinib in Lewy Body Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bosutinib in Lewy Body Dementia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Bosutinib in Lewy Body DementiaDrug Details:Bosutinib is under investigation for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fosgonimeton in Lewy Body Dementia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fosgonimeton in Lewy Body Dementia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Fosgonimeton in Lewy Body DementiaDrug Details:Fosgonimeton is under development for the treatment...